Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2002
11/28/2002CA2448253A1 Human cdnas and proteins and uses thereof
11/28/2002CA2448174A1 Compounds capable of modulating the activity and stimulating the production of a catalytic antibody
11/28/2002CA2448142A1 Beta-secretase substrates and uses thereof
11/28/2002CA2448092A1 Internalisation of virus into cells
11/28/2002CA2448014A1 Tsg101 as inhibitor of hiv production
11/28/2002CA2447958A1 Hypoxia inducible factors and uses thereof for inducing angiogenesis and improving muscular functions
11/28/2002CA2447948A1 Polynucleotide encoding a novel trp channel family member, trp-plik2, and splice variants thereof
11/28/2002CA2447942A1 A gene and uses therefor
11/28/2002CA2447933A1 A repressor-mediated regulation system for control of gene expression in plants
11/28/2002CA2447799A1 Emission ratiometric indicators of phosphorylation
11/28/2002CA2447795A1 Suppression of allergic reactions by transdermal administration of allergens in conjunction with or conjugated to toxin subunits or fragments thereof
11/28/2002CA2447647A1 Lipid-associated molecules
11/28/2002CA2447616A1 Vaccine composition
11/28/2002CA2447599A1 Peptide vaccines against group a streptococci
11/28/2002CA2447338A1 Receptors and membrane-associated proteins
11/28/2002CA2447236A1 Pulmonary administration of chemically modified insulin
11/28/2002CA2447215A1 Adherent entities and uses therefor
11/28/2002CA2446398A1 Nucleic acid and protein sequences of bovine epidermal growth factor
11/28/2002CA2445972A1 Methods and compositions for treating respiratory mucin production associated disease conditions
11/28/2002CA2444955A1 Inactivation of genes of the mep pathway
11/28/2002CA2443342A1 Mage-a3 peptides presented by hla class ii molecules
11/28/2002CA2441840A1 Human secreted proteins
11/28/2002CA2441801A1 Methods and formulations for increasing the affinity of a1 adenosine receptor ligands for the a1 adenosine receptor
11/28/2002CA2440368A1 Staphylococcus aureus proteins and nucleic acids
11/28/2002CA2440147A1 Nucleic acid and corresponding protein entitled 121p1f1 useful in treatment and detection of cancer
11/28/2002CA2434323A1 Sequence of the photorhabdus luminescens strain tt01 genome and uses
11/27/2002WO2001094575A1 Dna sequence regulating plant fruit-specific expression
11/27/2002EP1260591A1 High-efficiency assay for protein mannosyl transferases
11/27/2002EP1260585A1 Novel protein and gene encoding the same
11/27/2002EP1260584A1 Novel protein having signal sequence
11/27/2002EP1260582A1 Conjugates of factor IX and a biocompatible polymer
11/27/2002EP1260581A1 Cell usable in serum-free culture and suspension culture and process for producing virus for vaccine by using the cell
11/27/2002EP1260521A2 Immunoglobulin variants for specific Fc epsilon receptors
11/27/2002EP1260520A2 Chromosome 13-linked breast cancer susceptibility gene
11/27/2002EP1260519A1 Membrane receptors for steroids and sterols
11/27/2002EP1260228A2 Human growth gene and short stature gene region. Therapeutic uses
11/27/2002EP1259825A2 Method for carrying out the differential diagnostic determination of autoantibodies formed against the tsh receptor in a serum sample or plasma sample of a patient
11/27/2002EP1259821A1 Method of identifying modulators of presenilin
11/27/2002EP1259819A2 Diagnosis of bipolar affective disorder (bad) and unipolar depression
11/27/2002EP1259818A2 Diagnosis and treatment of schizophrenia
11/27/2002EP1259816A2 Prediction of hepatic failure following hepatitis c
11/27/2002EP1259814A1 Bcmp-7 as marker for diagnosis of breast cancer
11/27/2002EP1259813A2 Diagnosis and treatment of malignant neoplasms
11/27/2002EP1259812A2 Breast, gastric and prostate cancer associated antigens and uses therefor
11/27/2002EP1259650A2 Estrogen receptor alpha variants and methods of detection thereof
11/27/2002EP1259648A2 Diagnostics and therapeutics for glaucoma
11/27/2002EP1259642A1 Nucleic acids, proteins, and antibodies
11/27/2002EP1259639A2 Essential gene and gene products for identifying, developing and optimising immunological and pharmacological active ingredients for the treatment of microbial infections
11/27/2002EP1259637A2 Caspase-inhibitory-factor (cif) and uses thereof
11/27/2002EP1259629A2 Recombinant influenza a viruses
11/27/2002EP1259627A2 Heterologous expression of neisserial proteins
11/27/2002EP1259626A2 Materials and methods involving hybrid vascular endothelial growth factor dnas and proteins and screening methods for modulators
11/27/2002EP1259621A2 Lipid metabolism enzymes
11/27/2002EP1259617A2 Bunyaviridal reaper proteins and uses therefor
11/27/2002EP1259616A2 Tnf-alpha variants for the treatment of tnf-alpha related disorders
11/27/2002EP1259614A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/27/2002EP1259613A2 Human proteins and polynucleotides encoding the same
11/27/2002EP1259612A2 G-protein coupled receptor related polypeptides
11/27/2002EP1259611A2 G-protein coupled receptors
11/27/2002EP1259610A2 Human transporter proteins and polynucleotides encoding the same
11/27/2002EP1259609A2 Human schizophrenia gene
11/27/2002EP1259608A1 Modified fluorescent proteins
11/27/2002EP1259607A2 Protein and gene and their use for diagnosis and treatment of schizophrenia
11/27/2002EP1259606A2 Compositions useful for regulating parkin gene activity
11/27/2002EP1259605A2 Mutated cyclin g1 protein
11/27/2002EP1259604A1 Bcmp 84, a protein associated to breast cancer
11/27/2002EP1259601A2 Chimeric and tcr phage display libraries, chimeric and tcr reagents and methods of use thereof
11/27/2002EP1259597A2 Zinc finger domains and methods of identifying same
11/27/2002EP1259595A2 Integrin antagonists
11/27/2002EP1259591A2 Polypetptides and methods for thymic vaccination
11/27/2002EP1259546A1 Ccr2-64i, polymorphic variant of the human ccr2 receptor and its use in the diagnostic and treatment of atherosclerosis
11/27/2002EP1259545A2 Small cell lung cancer associated antigens and uses therefor
11/27/2002EP1259544A2 Heterologous polypeptide of the tnf family
11/27/2002EP1259543A1 Purification of vascular endothelial growth factor-b
11/27/2002EP1259542A2 Reagents and methods useful for detecting diseases of the breast
11/27/2002EP1259541A2 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei
11/27/2002EP1259540A1 Nucleic acids, proteins, and antibodies
11/27/2002EP1259539A1 Diagnosis and treatment of bipolar affective disorder
11/27/2002EP1259538A2 Proteins and nucleic acids encoding the same
11/27/2002EP1259536A2 Methods of peptide preparation
11/27/2002EP1259531A2 Nucleic acids, proteins, and antibodies
11/27/2002EP1259530A1 Melanoma differentiation associated gene - 5 and promoter and uses thereof
11/27/2002EP1259528A1 Nucleic acids, proteins and antibodies
11/27/2002EP1259527A1 35 human secreted proteins
11/27/2002EP1259526A2 Nucleic acids, proteins, and antibodies
11/27/2002EP1259258A1 Gm-negative ehv-mutants
11/27/2002EP1259255A1 Pai-2 conjugates for the treatment and imaging of cancer
11/27/2002EP1259253A2 Methods for promoting production of myelin by schwann cells
11/27/2002EP1259251A2 Novel method for down-regulation of amyloid
11/27/2002EP1259247A1 DNA ENCODING HUMAN ACID-SENSING ION CHANNEL BNaC4 (ASIC4)
11/27/2002EP1259245A2 Novel compositions and uses of dictyostatin compounds
11/27/2002EP1259223A1 Protein matrix materials, devices and methods of making and using thereof
11/27/2002EP1189920A4 Camello gene family and uses thereof
11/27/2002EP1019504A4 Isoforms of the human vitamin d receptor
11/27/2002EP0876500A4 Cold-active protease cp70
11/27/2002EP0871649B1 Conjugates of a polypeptide and a biocompatible polymer
11/27/2002EP0776331B1 Higher order structure and binding of peptide nucleic acids
11/27/2002EP0726907B1 Process for producing a virus-inactivated factor viii-containing fraction by chromatographic methods
11/27/2002EP0675961B1 Treatment of tumorigenic disease with a modified HSV
11/27/2002EP0671928B1 Synthesis of n-substituted oligomers
1 ... 1712 1713 1714 1715 1716 1717 1718 1719 1720 1721 1722 1723 1724 1725 1726 1727 1728 1729 1730 1731 1732 ... 2916